Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program
Journal article published in 2016 by
Antoine Adenis,
Christelle de la Fouchardiere 
,
Bernard Paule,
Pascal Burtin,
David Tougeron,
Jennifer Wallet,
Louis-Marie Dourthe,
Pierre-Luc Etienne,
Laurent Mineur,
Stéphanie Clisant,
Jean-Marc Phelip,
Andrew Kramar,
Thierry Andre
,
Bernard Paule,
Pascal Burtin,
David Tougeron,
Jennifer Wallet,
Louis-Marie Dourthe,
Pierre-Luc Etienne,
Laurent Mineur,
Stéphanie Clisant,
Jean-Marc Phelip,
Andrew Kramar,
Thierry Andre
This paper is made freely available by the publisher.
Full text: Download
Data provided by 